Dmgv is a rheostat of t cell survival and a potential therapeutic for inflammatory diseases and cancers

HIGHLIGHTS

• who: Fengyuan’ from the School of Basic Medical Sciences, Guangdong Provincial Key Laboratory of Allergy and Clinical Immunology, and the State Key Laboratory of Respiratory Diseases, Guangzhou Medical University, Guangzhou, China, Department of Orthopedics have published the research: DMGV Is a Rheostat of T Cell Survival and a Potential Therapeutic for Inflammatory Diseases and Cancers, in the Journal: (JOURNAL)
• what: The authors focused on ADMA since myo-inositol can be converted to myo-inositol 1,4,5trisphosphate (IP3), which activates calcium mobilization, a key T_cell activation pathway. Isolation of Human PBMCs For human PBMCs and . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.